Alnylam Pharmaceuticals (ALNY) Shares Issued (2010 - 2018)

Alnylam Pharmaceuticals' Shares Issued history runs 9 years deep, the most recent figure standing at $1.4 million for Q4 2018.

• Quarterly Shares Issued fell 84.4% year-over-year to $1.4 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $1.4 million (down 84.4% YoY) and the FY2018 annual result came in at $1.4 million, down 84.4% from the prior year.
• Shares Issued was $1.4 million for Q4 2018 at Alnylam Pharmaceuticals, down from $9.1 million in the prior quarter.
• Across five years, Shares Issued topped out at $9.1 million in Q4 2017 and bottomed at $639000.0 in Q4 2014.
• A 5-year average of $3.0 million and a median of $1.6 million in 2015 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2014 — Shares Issued sank 92.25% — and 2017, when it soared 286.13%.
• Alnylam Pharmaceuticals' Shares Issued stood at $639000.0 in 2014, then jumped by 156.96% to $1.6 million in 2015, then soared by 43.54% to $2.4 million in 2016, then surged by 286.13% to $9.1 million in 2017, then plunged by 84.4% to $1.4 million in 2018.
• Business Quant data shows ALNY's Shares Issued at $1.4 million in Q4 2018, $9.1 million in Q4 2017, and $2.4 million in Q4 2016.